- Clinical Outcomes of Initial Dexamethasone Treatment Combined with a Single High Dose of Intravenous Immunoglobulin for Primary Treatment of Kawasaki Disease
-
Lim YJ, Jung JW
- KMID: 1799489
- Yonsei Med J.
- 2014 Sep;55(5):1260-1266.
- doi: 10.3349/ymj.2014.55.5.1260
PURPOSE: To investigate the clinical effects of a single high dose intravenous immunoglobulin (IVIG) combined with initial dexamethasone as a primary treatment on Kawasaki disease (KD). MATERIALS AND METHODS: Between January... -
- CITED
-
- Close
- SHARE
-
- Close
- A Pilot Study of Bortezomib in Korean Patients with Relapsed or Refractory Myeloma
-
Lee KW, Yun T, Song EK, Na II, Shin H, Bang SM, Lee JH, Lee ST, Kim JH, Yoon SS, Lee JS, Park S, Kim BK, Kim NK
- KMID: 1712739
- J Korean Med Sci.
- 2005 Aug;20(4):598-602.
- doi: 10.3346/jkms.2005.20.4.598
Recent clinical trials showed that bortezomib, a novel proteasome inhibitor, had therapeutic activity in multiple myeloma. However, there was no data about the feasibility of bortezomib in Korean patients. We... -
- CITED
-
- Close
- SHARE
-
- Close
